E-LIB Suche - Ergebnisse für: Chalkias, Spyros

1

Interim Report of the Reactogenicity and Immunogenicity of ..:

Chalkias, Spyros ; McGhee, Nichole ; Whatley, Jordan L...
The Journal of Infectious Diseases. , 2024

Link: https://doi.org/10.1093/..

2

Humoral response superiority of the monovalent XBB.1.5 over..:

Lustig, Yaniv ; Barda, Noam ; Weiss-Ottolenghi, Yael...
Vaccine. , 2024

Link: https://doi.org/10.1016/..

3

Profiling antibody epitopes induced by mRNA-1273 vaccinatio..:

Girard, Bethany ; Baum-Jones, Elisabeth ; Best, Rebecca L....
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

4

2363. Three-Month Safety and Immunogenicity of Bivalent SAR..:

Lee, Ivan T ; Cosgrove, Catherine A ; Moore, Patrick...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

Three-month antibody persistence of a bivalent Omicron-cont..:

Chalkias, Spyros ; Harper, Charles ; Vrbicky, Keith...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivale..:

Chalkias, Spyros ; Whatley, Jordan L. ; Eder, Frank...
Nature Medicine. 29 (2023) 9 - p. 2325-2333 , 2023

Link: https://doi.org/10.1038/..

7

SARS-CoV-2 Omicron boosting induces de novo B cell response..:

Alsoussi, Wafaa B. ; Malladi, Sameer Kumar ; Zhou, Julian Q....
Nature. 617 (2023) 7961 - p. 592-598 , 2023

Link: https://doi.org/10.1038/..

8

Safety, immunogenicity and antibody persistence of a bivale..:

Chalkias, Spyros ; Eder, Frank ; Essink, Brandon...
Nature Medicine. 28 (2022) 11 - p. 2388-2397 , 2022

Link: https://doi.org/10.1038/..

9

LB750. Safety and Immunogenicity of a Bivalent Omicron-Cont..:

Chalkias, Spyros ; Harper, Charles ; Vrbicky, Keith...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

10

EMBARK: A Phase 3b, Open-Label, Single-Arm, Safety Study to..:

Castrillo-Viguera, Carmen ; Chalkias, Spyros ; Burkett, Patrick...
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

11

Considerations for the real‐world management of ARIA from t..:

Burkett, Patrick ; Chalkias, Spyros ; Umans, Kimberly...
Alzheimer's & Dementia. 17 (2021) S9 - p. , 2021

Link: https://doi.org/10.1002/..

12

EMERGE et ENGAGE : premiers résultats des études de phase I..:

Haeberlein, Samantha Budd ; Von Hehn, Christian ; Tian, Ying...
Revue Neurologique. 177 (2021) - p. S2 , 2021

Link: https://doi.org/10.1016/..

13

Emerge and Engage topline results: Phase 3 studies of aduca..:

Haeberlein, Samantha Budd ; von Hehn, Christian ; Tian, Ying...
Alzheimer's & Dementia. 16 (2020) S9 - p. , 2020

Link: https://doi.org/10.1002/..

14

Long-term safety and efficacy of daclizumab beta in relapsi..:

Gold, Ralf ; Radue, Ernst-Wilhelm ; Giovannoni, Gavin...
Journal of Neurology. 267 (2020) 10 - p. 2851-2864 , 2020

Link: https://doi.org/10.1007/..

15

Interim Analyses of Fixed-Dose and Titration Cohorts from P..:

Castrillo-Viguera, Carmen ; Haeberlein, Samantha Budd ; Von Rosenstiel, Philipp...
Neurology. 92 (2019) 15_supplement - p. , 2019

Link: https://doi.org/10.1212/..